Floyd "Money" Mayweather and Connor McGregor, both highly esteemed fighters in their own right, have been dancing around and toward each other over the past year, working to what is one of most highly…
Calithera Biosciences shares made a decent gain early on Wednesday after the company announced that it had been granted a Fast Track Designation by the FDA.
Shares of Inovio Pharmaceuticals saw a handy gain early on Wednesday after the company gave an update on its Zika virus study.
Ambarella, Inc. (NASDAQ: AMBA) reported its fiscal first-quarter financial results after the markets closed on Tuesday. The company said that it had $0.39 in earnings per share (EPS) and $64.1 million in revenue, compared…
Overall Tuesday was again a relatively flat day for the broad markets. Crude oil made an incredible recovery over the course of the day to currently be positive over 1%, oil & gas stocks…
Celldex Therapeutics was another big mover coming out of the Annual Meeting for the American Society of Clinical Oncology (ASCO). Unfortunately, the move was to the downside.
Merrill Lynch has identified eight entry points for investors who want to play the robots and artificial intelligence theme, with some stock picks for each.
These younger generations are embracing diversity, sustainability, globalization, disruptive technology, "peak stuff," new business models and entrepreneurialism like no generation before them.
Shares of Albany Molecular Research saw a handy gain on Tuesday after it was announced that the company signed a definitive agreement to be acquired.
Athenex expects to price 6 million shares in the range of $11 to $13 apiece for an initial public offering is valued up to more than $89 million.
Although Conn's reported fiscal first-quarter financial results that were more or less in line with expectations, this was not enough for investors.
Overall Monday was a relatively flat day for the broad markets. Despite crude oil sliding lower on the day, Oil & Gas stocks were relatively mixed, with the likes of Exxon actually posting a…
Juno Therapeutics aw its shares slide after the company reported updated clinical trial results at the Annual Meeting for the American Society of Clinical Oncology (ASCO).
Merrill Lynch has updated its Bull Trenders List and 24/7 Wall St. has taken a quick look at these companies.
24/7 Wall St. had the chance to review these analyst reports that are moving some social media stocks on Monday, and we have included some of the highlights.
Forestar Group saw its shares make a solid gain to kick off the week after D.R. Horton announced that it aimed to acquire a huge portion of Forestar's outstanding shares.
Aileron Therapeutics has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
The Annual Meeting for the American Society of Clinical Oncology (ASCO) is currently underway in Chicago, and the health care sector is on the move.
Analysts have taken the perspective that the Walgreens/Rite Aid deal might be too difficult to call correctly, and those covering it generally have created two scenarios about what could happen.
New York-based luxury fashion company Michael Kors has been the victim of an incredibly challenging retail environment, and it doesn’t seem like the latest earnings helped out.
